Chief Business Officer
Darren has 20 years of broad commercial expertise from a range of experiences with CDMOs, therapeutics, and software companies. Most recently, he held leadership positions in Cell and Gene Therapy at Thermo Fisher Scientific while also being deeply involved in the manufacturing response to the Covid-19 pandemic. As Head of Commercial Operations, he helped build and lead both GMP Plasmid and GMP Cell Therapy businesses. Darren’s diverse experiences in the software industry has helped him develop a deep understanding of data-driven processes.
Prior to joining Thermo Fisher, Darren held various commercial roles at several start-ups and growth-stage companies, including IntroMaps, Althea Technologies (now Ajinomoto), Cerimon Pharmaceuticals, and Seven Bridges Genomics.